Key result
Low TAPSE with normal PVR linked to ~7.2-fold higher 6-year mortality in PH-LHD.
Why the study?
To evaluate whether supervised machine learning with decision tree analysis confirms the risk stratification of PVR < 3WU for identifying low risk in pulmonary hypertension due to left heart disease.
Cohort (n=202)
Investigator-blinded
Yes
Answers are grounded in this paper and cite their sources.
In patients with pulmonary hypertension due to left heart disease, a low PVR (<3 WU) paradoxically predicts the worst mortality when accompanied by right ventricular dysfunction (TAPSE <16 mm).
Aims In 2019, pulmonary vascular resistance (PVR) < 3WU was adopted to stratify patients at low risk in pulmonary hypertension due to left heart disease (PH-LHD) as well those with isolated PH-LHD. We sought to evaluate whether supervised machine learning with decision tree analysis, which provides more information than Cox Proportional analysis by forming a hierarchy of multiple covariates, confirms this risk stratification. Methods and results Two hundred two consecutive patients (mean age: 69 ± 11 years, female: 42%) with mean pulmonary artery pressure ≥ 20 mmHg and wedge pressure > 15 mmHg were recruited. Transpulmonary pressure gradient ⩾̸ 12 mmHg, PVR ⩾̸ 3WU, diastolic pressure gradient ⩾̸ 7 mmHg, pulmonary arterial capacitance < 1.1 mL/mmHg, tricuspid annular plane systolic excursion (TAPSE) < 16 mm, peak systolic tissue Doppler velocity < 10 cm/s, right ventricular end-diastolic area ⩾̸ 25 cm2 were the seven categorical values entered into the model due to their prognostic significance in PH. We used the chi-squared automatic interaction detection method to predict mortality. Each node and branch were compared using survival analysis at 6-year follow-up. Mean pulmonary artery pressure, wedge pressure, cardiac index, and PVR were 40.3 ± 10.0 mmHg, 22.3 ± 7.1 mmHg, 2.9 ± 0.8 L/min/m2, and 3.6 ± 2.1WU, respectively. Among the seven dichotomous, TAPSE was first selected following by PVR. Compared with patients with PVR < 3WU and TAPSE ⩾̸ 16 mm, patients with PVR ⩾̸ 3WU and TAPSE ⩾̸ 16 mm, or patients with PVR ⩾̸ 3WU and TAPSE<16 mm had significantly increased mortality, HR = 3.0, 95% CI = [1.4–6.4], P = 0.006 and HR = 3.3, 95% CI = [1.6–6.9], P = 0.002, respectively, while patients with PVR < 3WU and TAPSE < 16 mm exhibited the worst prognosis, HR = 7.2, 95% CI = [3.3–15.9], P = 0.0001. Conclusions Used for solving regression and classification problems, decision tree analysis confirms that PVR and TAPSE have to be analysed together in PH-LHD and revealed the dangerous and contradictory prognostic significance of PVR < 3WU when TAPSE<16 mm.
No takes yet. Share an insight, caveat, or question.
Raitiere et al. (2020) conducted a cohort in Postcapillary pulmonary hypertension due to left heart disease (PH-LHD) (n=202). PVR < 3 WU and TAPSE < 16 mm vs. PVR < 3 WU and TAPSE ≥ 16 mm was evaluated on All-cause mortality (cardiac or non-cardiac death) at 6-year follow-up (HR 7.2, 95% CI 3.3-15.9, p=0.0001). PVR < 3 WU combined with TAPSE < 16 mm was associated with the worst 6-year mortality in PH-LHD patients compared to PVR < 3 WU and TAPSE ≥ 16 mm (HR 7.2, 95% CI 3.3-15.9, P = 0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: